Education and Expertise

• 2002-2008 Istanbul University Cerrahpaşa Faculty of Medicine
• 2009-2013 Research Assistant, Istanbul Şişli Etfal Training and Research Hospital, Department of Internal Medicine
• 2013-2014 Specialist Doctor, Erzin State Hospital, Department of Internal Medicine
• 2014-2017 Research Assistant, Istanbul Faculty of Medicine, Hematology Clinic
• 2017-2019 Specialist Doctor, Adıyaman University Training and Research Hospital, Hematology Clinic
• 2019-2020 Specialist Doctor, Istanbul Şişli Hamidiye Etfal Training and Research Hospital, Hematology Clinic
• 2020-2022 Specialist Doctor, Yeditepe University Hospital, Hematology Clinic

Courses and Certifications

• 2014 Good Clinical Practice Course, Istanbul
• 2014 Biostatistics Training Course, Istanbul
• 2016-2017 European Hematology Association Masterclass

Professional Memberships

• Turkish Society of Hematology
• European Hematology Association

Awards

• 2016 Young Researcher Award, National Hematology Congress
• 2002 Best Seven Presentations Award, Lymphoma Leukemia Myeloma Congress

Articles Published in International Peer-Reviewed Journals (SCI,SSCI,ArtsandHumanities)

1) Özkan SG, Pata C, Şekuri A, Çınar Y, Özkan HA. Transient elastography of liver: Could it be a guide for diagnosis and management strategy in hepatic veno-occlusive disease (sinusoidal obstruction syndrome)? Transfus Apher Sci. 2022 Feb;61(1):103370. doi: 10.1016/j.transci.2022.103370. Epub 2022 Jan 24.

2) Özkan HA, Özkan SG .Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment. Transfus Apher Sci. 2022 Feb;61(1):103372. doi: 10.1016/j.transci.2022.103372. Epub 2022 Jan 22.

3) Ozkan SG, Yazısız H, Behlül A, Gökbelen YA, Borlu F, Yazısız V. Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis. Eur J Rheumatol. 2017 Mar;4(1):40-45. doi: 10.5152/eurjrheum.2017.16052. Epub 2017 Mar 1.

4) Turan Erkek E, Demir N, Ozkan G, Yavuz AS. Testicular and Cutaneous Relapse in Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Chemotherapy. Eurasian Journal of Medicine and Oncology. Volume 1, Issue 1,2017. doi: 10.14744/ejmo.2017.87597 Pages 53-54

5) Demir S, Gelincik A, Coskun R, Ozkan G, Demir N, Paksoy N, Beyaz S, Colakoglu B, Kalayoglu-Besisik S, Nalcacı M, Buyukozturk S. A practical 16-day desensitization protocol in lenalidomide-induced non-immediate hypersensitivity reactions. Ann Allergy Asthma Immunol. 2019 Oct;123(4):394-397. doi: 10.1016/j.anai.2019.07.031. Epub 2019 Aug 7.

6) Atci T, Yazganoglu KD, Yonal I, Ekinci AP1, Kaplan SG, Babuna G, Besisik S, Baykal C.Lichen myxedematosus: eine Fallserie mit Schwerpunkt auf klinischen Merkmalen, Krankheitsassoziationen und Behandlung. J Dtsch Dermatol Ges. 2017 Feb;15(2):214-217. doi: 10.1111/ddg.12970_g.

7) Avcı S, Selcukbiricik F, Bilici A, Ozkan G, Ozağarı AA, Borlu F. Squamous cell carcinoma arising in a mature cystic teratoma. Case Rep Obstet Gynecol. 2012;2012:314535. doi: 10.1155/2012/314535. Epub 2012 Dec 23.

8) Gunes AK, Serin I, Demir I, Sarifakiogullari S, Durusoy SS, Akkurt DM, Ince I, Ozkan G, Cinli TA, Pehlivan M. Comparison of mitoxantrone-melphalan and BEAM conditioning regimens in patients with lymphoma. Hematol Oncol Stem Cell Ther. 2021 Apr 17:S1658-3876(21)00034-0. doi: 10.1016/j.hemonc.2021.03.005.

9) Öztop N, Özer PK, Demir S, Beyaz Ş, Tiryaki TO, Özkan G, Aydogan M, Bugra MZ, Çolakoglu B, Büyüköztürk S, Nalçacı M, Yavuz AS, Gelincik A. Impaired endothelial function irrespective of systemic inflammation or atherosclerosis in mastocytosis. Ann Allergy Asthma Immunol. 2021 Jul;127(1):76-82. doi: 10.1016/j.anai.2021.03.020. Epub 2021 Mar 26

10) Tiryaki TO, Ozkan SO, Erdem S, et al. Comprehensive Mastocytosis Data Analysis From A Single Center. Research Square June 29th, 2022, DOI: https://doi.org/10.21203/rs.3.rs-1801037/v1

Kitap Bölümleri
1.Özkan G, BCL-2 inhibitors in Chronic Lymphocytic Leukemia pp:103-115; in Chronic Lymhpocytic Leukemia , Akademisyen Bookstore, Ankara,2019
2. Özkan G, Management of hematologic side effects of targeted therapies pp:325-332, in Targeted Therapies in Oncology, Akademisyen Bookstıre,Ankara, 2020

Ulusal Kongrelerde Sözel Sunumlar
Ozkan G, Dogan O, Tepe O, Arslan O, Yavuz AS,The new differential diagnosis of CD30-positive neoplasms: Mastocytosis.  42^th National Hematology Congress,2016 (National Hematology Congress, Young Researcher award) 
Ozkan G, Demir N, Dogan O, Baykal C, Buyukbabani N, Tanakol R, Tanrıkulu S, Yavuz As. Adult Mastocytosis: Single Centre Experience.. 42^th National Hematology Congress,2016
Ozkan G, Yavuz As. Late Diagnosis of  a Mastocytosis: A case presentation. 6^th Experimental Hematology Congress, 2019
Özkan SG, Kaya E, Erkurt ME , Sarıcı A, Berber I, Kuku I.Ibrutinib Experience in Graft Versus Host Disease: Single Centre Experience. 45^th National Hematology Congress,2019
Özkan G, Özkan A. Granulocyte transfusion: Single Centre Experience . 15^th Apheresis Congress 2020Özkan G, Bal C, Özkan A. comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. 13th. National Bone Marrow Transplantation and Cell Therapies Congress 2021
Özkan G, Şekuri A, Çınar Y, Özkan A. Effect of levofloxacin prophylaxis in patients with stem cell transplantation. 13th. National Bone Marrow Transplantation and Cell Therapies Congress 2021
Özkan G, Özkan A, Primary central nervous system lymphomas: Single center experience Leukemia Lymphoma Myelom Congress 2022

Uluslararası Kongrelerde Bildiriler
Ozkan G, Demir N, Dogan O, Baykal C, Buyukbabani N, Tanakol R, Tanrıkulu S, Yavuz As. Adult Mastocytosis: Single Centre Experience.22 ^th  European Hematology Congress, 2017